FDA Brief

Warning letters Food

FDA warning letter to

H2 Beverages, Inc.

High riskIssued Jun 14, 2022Posted Jul 19, 2022Division of Human and Animal Food Operations West III

H2 Beverages' hydrogen-infused water beverages are unapproved new drugs and misbranded because of disease and COVID-19 claims.

What happened

FDA inspected H2 Beverages’ Plano, TX beverage facility from November 8 through November 10, 2021 and collected product labels. In March 2022 FDA reviewed the company website and Facebook page and found claims that the hydrogen-infused water products treat or prevent diseases, including a claim that Silver Bullet Green Tea with Zinc fights COVID-19. FDA also found label and ingredient-declaration problems, including missing common names, missing manufacturer information, and inconsistent or incomplete ingredient listings.

What FDA found

  1. The website claims make Hydro Shot, Silver Bullet Green Tea with Zinc, and Hydro Brew Unsweetened Green Tea unapproved new drugs, which cannot be sold without FDA approval.

    FD&C Act sections 201(g)(1)(B), 201(p), 301(d), 505(a) [21 U.S.C. 321(g)(1)(B), 321(p), 331(d), 355(a)]
  2. The products are misbranded because their labels do not give adequate directions for safe use by a layperson for the claimed disease uses.

    FD&C Act section 502(f)(1) [21 U.S.C. 352(f)(1)]; 21 CFR 201.5
  3. Hydro Shot’s label does not state a common or usual name for the food on the principal display panel.

    FD&C Act section 403(i)(1) [21 U.S.C. 343(i)(1)]; 21 CFR 101.3
  4. The labels for all three products do not include the name and place of business of the manufacturer, packer, or distributor.

    FD&C Act section 403(e)(1) [21 U.S.C. 343(e)(1)]; 21 CFR 101.5
  5. The labels do not list each ingredient by a common or usual name: hydrogen is not declared, “RO” is not a common name, and “stevia” is too vague.

    FD&C Act section 403(i)(2) [21 U.S.C. 343(i)(2)]; 21 CFR 101.4
  6. A website Nutrition Facts image says Hydro Brew Unsweetened Green Tea contains 10 mg CBD per serving although the label does not declare CBD, and FDA considers CBD an unsafe food additive in conventional foods.

    FD&C Act sections 403(a)(1), 403(i)(2), 409(a) [21 U.S.C. 343(a)(1), 343(i)(2), 348(a)]

What FDA wants

FDA asks H2 Beverages to take immediate action to stop selling any unapproved or unauthorized products for COVID-19 and to notify FDA in writing within 15 working days of the steps taken to correct the violations, including how it will prevent recurrence and related documentation.

Who should pay attention

  • beverage brands making disease or COVID-19 claims
  • food and supplement companies using CBD, stevia, or vitamin D in beverages
  • retailers and distributors selling hydrogen-infused or functional beverages

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk